Eva Möller

Title: Eva Möller - Innovator in Pharmaceutical Chemistry

Introduction

Eva Möller is a distinguished inventor based in Södertälje, Sweden. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. Her work has led to advancements that benefit both the pharmaceutical industry and patients worldwide.

Latest Patents

Eva Möller holds a patent for a novel form of S-omeprazole. The patent describes a new form of the (-)-enantiomer of 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl-1-benzimidazole, specifically the magnesium salt of the S-enantiomer of omeprazole trihydrate. This invention also includes processes for preparing this form and pharmaceutical compositions containing it, along with new intermediates used in the process.

Career Highlights

Eva Möller is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. Her role involves research and development in drug formulation, where she applies her expertise to create innovative solutions for various health challenges.

Collaborations

Throughout her career, Eva has collaborated with notable colleagues, including Anders Mattson and Hanna Cotton. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical sector.

Conclusion

Eva Möller exemplifies the spirit of innovation in pharmaceutical chemistry through her groundbreaking work on S-omeprazole. Her contributions continue to impact the industry positively, showcasing the importance of research and collaboration in developing effective medical solutions.